Two Sigma Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-55,200
Closed -$3.54M 2706
2018
Q4
$3.54M Sell
55,200
-46,400
-46% -$3.43M 0.04% 223
2018
Q3
$9.09M Sell
101,600
-142,200
-58% -$12.6M 0.06% 231
2018
Q2
$19.4M Buy
243,800
+39,000
+19% +$3.24M 0.1% 158
2018
Q1
$18.3M Buy
204,800
+182,100
+802% +$17.5M 0.1% 171
2017
Q4
$2.37M Buy
+22,700
New +$2.56M 0.06% 231

Other funds holding CELG

Two Sigma Securities's CELG Position: Q4 2019 in Review

Two Sigma Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,918 shares — an estimated $687K sold.

Two Sigma Securities first reported a position in CELG in Q4 2014 and held it in 14 quarters. The position peaked at $3.15M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Two Sigma Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Securities sold 6,918 Celgene Corp shares in Q4 2019, an estimated $687K.
  • Two Sigma Securities first reported a position in Celgene Corp in Q4 2014 and held it in 14 quarters.
  • Two Sigma Securities's Celgene Corp position peaked at $3.15M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Two Sigma Securities's 13F filing for Q4 2019, filed 14 Feb 2020.